{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T07:44:12Z","timestamp":1773906252010,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"ProCardio Center for Innovation, Department of Cardiology, Oslo University Hospital"},{"DOI":"10.13039\/100008730","name":"The Norwegian Cancer Society","doi-asserted-by":"crossref","award":["202076"],"award-info":[{"award-number":["202076"]}],"id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Aktiv mot kreft"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardio-Oncology"],"DOI":"10.1186\/s40959-024-00296-0","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T07:18:55Z","timestamp":1735975135000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cardiorespiratory fitness, cardiac morphology and function, and cardiovascular risk factors in long-term breast cancer survivors compared with non-cancer controls"],"prefix":"10.1186","volume":"11","author":[{"given":"Mali","family":"S\u00e6ter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara Hassing","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin Valborg","family":"Reinertsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lene","family":"Thorsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina Hermann","family":"Haugaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tormod Skogstad","family":"Nilsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian Imre","family":"Sarvari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,4]]},"reference":[{"key":"296_CR1","unstructured":"Cancer Registry of Norway. Cancer in Norway 2022- Cancer incidence, mortality, survival and prevalence in Norway. https:\/\/www.kreftregisteret.no\/globalassets\/cancer-in-norway\/2022\/cin_report-2022.pdf (2023). Accessed 20.02 2024."},{"issue":"11","key":"296_CR2","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1200\/jco.1998.16.11.3502","volume":"16","author":"M Ryberg","year":"1998","unstructured":"Ryberg M, Nielsen D, Skovsgaard T, Hansen J, Jensen BV, Dombernowsky P. Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer. J Clin Oncol. 1998;16(11):3502\u20138. https:\/\/doi.org\/10.1200\/jco.1998.16.11.3502.","journal-title":"J Clin Oncol"},{"issue":"5","key":"296_CR3","doi-asserted-by":"publisher","first-page":"710","DOI":"10.7326\/0003-4819-91-5-710","volume":"91","author":"DD Von Hoff","year":"1979","unstructured":"Von Hoff DD, Layard MW, Basa P, Davis HL Jr., Hoff V, Rozencweig AL. Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med. 1979;91(5):710\u20137. https:\/\/doi.org\/10.7326\/0003-4819-91-5-710.","journal-title":"Ann Intern Med"},{"issue":"10","key":"296_CR4","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1002\/ejhf.1168","volume":"20","author":"A Banke","year":"2018","unstructured":"Banke A, Fosb\u00f8l EL, M\u00f8ller JE, Gislason GH, Andersen M, Bernsdorf M, et al. Long-term effect of epirubicin on incidence of heart failure in women with breast cancer: insight from a randomized clinical trial. Eur J Heart Fail. 2018;20(10):1447\u201353. https:\/\/doi.org\/10.1002\/ejhf.1168.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"296_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10549-020-05930-w","volume":"185","author":"JN Jacobse","year":"2021","unstructured":"Jacobse JN, Schaapveld M, Boekel NB, Hooning MJ, Jager A, Baaijens MHA, et al. Risk of heart failure after systemic treatment for early breast cancer: results of a cohort study. Breast Cancer Res Treat. 2021;185(1):205\u201314. https:\/\/doi.org\/10.1007\/s10549-020-05930-w.","journal-title":"Breast Cancer Res Treat"},{"key":"296_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ejca.2017.05.013","volume":"81","author":"LM Boerman","year":"2017","unstructured":"Boerman LM, Maass S, van der Meer P, Gietema JA, Maduro JH, Hummel YM, et al. Long-term outcome of cardiac function in a population-based cohort of breast cancer survivors: a cross-sectional study. Eur J Cancer. 2017;81:56\u201365. https:\/\/doi.org\/10.1016\/j.ejca.2017.05.013.","journal-title":"Eur J Cancer"},{"issue":"1","key":"296_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1200\/jco.2001.19.1.37","volume":"19","author":"M Zambetti","year":"2001","unstructured":"Zambetti M, Moliterni A, Materazzo C, Stefanelli M, Cipriani S, Valagussa P, et al. Long-term cardiac sequelae in operable breast cancer patients given adjuvant chemotherapy with or without doxorubicin and breast irradiation. J Clin Oncol. 2001;19(1):37\u201343. https:\/\/doi.org\/10.1200\/jco.2001.19.1.37.","journal-title":"J Clin Oncol"},{"issue":"2","key":"296_CR8","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/ejhf.1610","volume":"22","author":"JN Jacobse","year":"2020","unstructured":"Jacobse JN, Steggink LC, Sonke GS, Schaapveld M, Hummel YM, Steenbruggen TG, et al. Myocardial dysfunction in long-term breast cancer survivors treated at ages 40\u201350 years. Eur J Heart Fail. 2020;22(2):338\u201346. https:\/\/doi.org\/10.1002\/ejhf.1610.","journal-title":"Eur J Heart Fail"},{"issue":"19","key":"296_CR9","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1001\/jama.2009.681","volume":"301","author":"S Kodama","year":"2009","unstructured":"Kodama S, Saito K, Tanaka S, Maki M, Yachi Y, Asumi M, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA. 2009;301(19):2024\u201335. https:\/\/doi.org\/10.1001\/jama.2009.681.","journal-title":"JAMA"},{"issue":"1","key":"296_CR10","doi-asserted-by":"publisher","first-page":"e000432","DOI":"10.1161\/jaha.113.000432","volume":"3","author":"AB Peel","year":"2014","unstructured":"Peel AB, Thomas SM, Dittus K, Jones LW, Lakoski SG. Cardiorespiratory fitness in breast cancer patients: a call for normative values. J Am Heart Assoc. 2014;3(1):e000432. https:\/\/doi.org\/10.1161\/jaha.113.000432.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"296_CR11","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s10549-013-2818-1","volume":"143","author":"MG Khouri","year":"2014","unstructured":"Khouri MG, Hornsby WE, Risum N, Velazquez EJ, Thomas S, Lane A, et al. Utility of 3-dimensional echocardiography, global longitudinal strain, and exercise stress echocardiography to detect cardiac dysfunction in breast cancer patients treated with doxorubicin-containing adjuvant therapy. Breast Cancer Res Treat. 2014;143(3):531\u20139. https:\/\/doi.org\/10.1007\/s10549-013-2818-1.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"296_CR12","doi-asserted-by":"publisher","first-page":"14005","DOI":"10.1038\/s41598-021-93241-5","volume":"11","author":"AA Kirkham","year":"2021","unstructured":"Kirkham AA, Haykowsky MJ, Beaudry RI, Grenier JG, Mackey JR, Pituskin E, et al. Cardiac and skeletal muscle predictors of impaired cardiorespiratory fitness post-anthracycline chemotherapy for breast cancer. Sci Rep. 2021;11(1):14005. https:\/\/doi.org\/10.1038\/s41598-021-93241-5.","journal-title":"Sci Rep"},{"issue":"10","key":"296_CR13","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1634\/theoncologist.12-10-1156","volume":"12","author":"LW Jones","year":"2007","unstructured":"Jones LW, Haykowsky M, Pituskin EN, Jendzjowsky NG, Tomczak CR, Haennel RG, et al. Cardiovascular reserve and risk profile of postmenopausal women after chemoendocrine therapy for hormone receptor\u2013positive operable breast cancer. Oncologist. 2007;12(10):1156\u201364. https:\/\/doi.org\/10.1634\/theoncologist.12-10-1156.","journal-title":"Oncologist"},{"issue":"2","key":"296_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1634\/theoncologist.2015-0352","volume":"21","author":"GJ Koelwyn","year":"2016","unstructured":"Koelwyn GJ, Lewis NC, Ellard SL, Jones LW, Gelinas JC, Rolf JD, et al. Ventricular-arterial coupling in breast Cancer patients after treatment with anthracycline-containing adjuvant chemotherapy. Oncologist. 2016;21(2):141\u20139. https:\/\/doi.org\/10.1634\/theoncologist.2015-0352.","journal-title":"Oncologist"},{"issue":"1","key":"296_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40959-022-00134-1","volume":"8","author":"RI Beaudry","year":"2022","unstructured":"Beaudry RI, Haykowsky MJ, MacNamara JP, Tucker WJ, Rao R, Haley B, et al. Cardiac mechanisms for low aerobic power in anthracycline treated, older, long-term breast cancer survivors. Cardiooncology. 2022;8(1):8. https:\/\/doi.org\/10.1186\/s40959-022-00134-1.","journal-title":"Cardiooncology"},{"issue":"3","key":"296_CR16","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s10549-013-2478-1","volume":"138","author":"SG Lakoski","year":"2013","unstructured":"Lakoski SG, Barlow CE, Koelwyn GJ, Hornsby WE, Hernandez J, Defina LF, et al. The influence of adjuvant therapy on cardiorespiratory fitness in early-stage breast cancer seven years after diagnosis: the Cooper Center Longitudinal Study. Breast Cancer Res Treat. 2013;138(3):909\u201316. https:\/\/doi.org\/10.1007\/s10549-013-2478-1.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"296_CR17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/jnci\/djaa096","volume":"113","author":"C Ramin","year":"2021","unstructured":"Ramin C, Schaeffer ML, Zheng Z, Connor AE, Hoffman-Bolton J, Lau B, et al. All-cause and Cardiovascular Disease Mortality among breast Cancer survivors in CLUE II, a long-Standing Community-based cohort. J Natl Cancer Inst. 2021;113(2):137\u201345. https:\/\/doi.org\/10.1093\/jnci\/djaa096.","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"296_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/s1470-2045(05)70251-5","volume":"6","author":"SC Darby","year":"2005","unstructured":"Darby SC, McGale P, Taylor CW, Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 2005;6(8):557\u201365. https:\/\/doi.org\/10.1016\/s1470-2045(05)70251-5.","journal-title":"Lancet Oncol"},{"issue":"17","key":"296_CR19","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1093\/jnci\/djr242","volume":"103","author":"E Amir","year":"2011","unstructured":"Amir E, Seruga B, Niraula S, Carlsson L, Oca\u00f1a A. Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis. J Natl Cancer Inst. 2011;103(17):1299\u2013309. https:\/\/doi.org\/10.1093\/jnci\/djr242.","journal-title":"J Natl Cancer Inst"},{"key":"296_CR20","doi-asserted-by":"publisher","first-page":"e45244","DOI":"10.2196\/45244","volume":"12","author":"TS Nilsen","year":"2023","unstructured":"Nilsen TS, S\u00e6ter M, Sarvari SI, Reinertsen KV, Johansen SH, Edvardsen ER, et al. Effects of Aerobic Exercise on Cardiorespiratory Fitness, Cardiovascular Risk factors, and patient-reported outcomes in long-term breast Cancer survivors: protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2023;12:e45244. https:\/\/doi.org\/10.2196\/45244.","journal-title":"JMIR Res Protoc"},{"key":"296_CR21","unstructured":"Helsedirektoratet. Nasjonal faglig retningslinje for forebygging av hjerte- og karsykdom [nettdokument]. https:\/\/www.helsedirektoratet.no\/retningslinjer\/forebygging-av-hjerte-og-karsykdom (2017). Accessed 22.02 2024."},{"issue":"3","key":"296_CR22","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1002\/ehf2.13906","volume":"9","author":"M Averina","year":"2022","unstructured":"Averina M, Stylidis M, Brox J, Schirmer H. NT-ProBNP and high-sensitivity troponin T as screening tests for subclinical chronic heart failure in a general population. ESC Heart Fail. 2022;9(3):1954\u201362. https:\/\/doi.org\/10.1002\/ehf2.13906.","journal-title":"ESC Heart Fail"},{"issue":"3","key":"296_CR23","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s11764-015-0430-6","volume":"9","author":"S Amireault","year":"2015","unstructured":"Amireault S, Godin G, Lacombe J, Sabiston CM. Validation of the Godin-Shephard leisure-time physical activity questionnaire classification coding system using accelerometer assessment among breast cancer survivors. J Cancer Surviv. 2015;9(3):532\u201340. https:\/\/doi.org\/10.1007\/s11764-015-0430-6.","journal-title":"J Cancer Surviv"},{"issue":"24","key":"296_CR24","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1136\/bjsports-2020-102955","volume":"54","author":"FC Bull","year":"2020","unstructured":"Bull FC, Al-Ansari SS, Biddle S, Borodulin K, Buman MP, Cardon G, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020;54(24):1451\u201362. https:\/\/doi.org\/10.1136\/bjsports-2020-102955.","journal-title":"Br J Sports Med"},{"issue":"1","key":"296_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1\u2013e3914. https:\/\/doi.org\/10.1016\/j.echo.2014.10.003.","journal-title":"J Am Soc Echocardiogr"},{"issue":"8","key":"296_CR26","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1093\/ehjci\/jex140","volume":"18","author":"T Sugimoto","year":"2017","unstructured":"Sugimoto T, Dulgheru R, Bernard A, Ilardi F, Contu L, Addetia K, et al. Echocardiographic reference ranges for normal left ventricular 2D strain: results from the EACVI NORRE study. Eur Heart J Cardiovasc Imaging. 2017;18(8):833\u201340. https:\/\/doi.org\/10.1093\/ehjci\/jex140.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"296_CR27","doi-asserted-by":"publisher","unstructured":"Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, et al. Recommendations for the evaluation of left ventricular diastolic function by Echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29(4):277\u2013314. https:\/\/doi.org\/10.1016\/j.echo.2016.01.011.","DOI":"10.1016\/j.echo.2016.01.011"},{"issue":"2","key":"296_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1161\/CIR.0b013e3181e52e69","volume":"122","author":"GJ Balady","year":"2010","unstructured":"Balady GJ, Arena R, Sietsema K, Myers J, Coke L, Fletcher GF, et al. Clinician\u2019s guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation. 2010;122(2):191\u2013225. https:\/\/doi.org\/10.1161\/CIR.0b013e3181e52e69.","journal-title":"Circulation"},{"issue":"1","key":"296_CR29","doi-asserted-by":"publisher","first-page":"e85276","DOI":"10.1371\/journal.pone.0085276","volume":"9","author":"E Edvardsen","year":"2014","unstructured":"Edvardsen E, Hem E, Anderssen SA. End criteria for reaching maximal oxygen uptake must be strict and adjusted to sex and age: a cross-sectional study. PLoS ONE. 2014;9(1):e85276. https:\/\/doi.org\/10.1371\/journal.pone.0085276.","journal-title":"PLoS ONE"},{"key":"296_CR30","doi-asserted-by":"publisher","unstructured":"Giske\u00f8deg\u00e5rd GF, Lydersen S. Measurements below the detection limit. Tidsskr nor Laegeforen. 2022;142(13). https:\/\/doi.org\/10.4045\/tidsskr.22.0439.","DOI":"10.4045\/tidsskr.22.0439"},{"issue":"6","key":"296_CR31","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/cpf.12845","volume":"43","author":"A St\u00f8ylen","year":"2023","unstructured":"St\u00f8ylen A, M\u00f8lmen HE, Dalen H. Regional motion of the AV-plane is related to the cardiac anatomy and deformation of the AV-plane. Data from the HUNT study. Clin Physiol Funct Imaging. 2023;43(6):453\u201362. https:\/\/doi.org\/10.1111\/cpf.12845.","journal-title":"Clin Physiol Funct Imaging"},{"issue":"11","key":"296_CR32","doi-asserted-by":"publisher","first-page":"e113884","DOI":"10.1371\/journal.pone.0113884","volume":"9","author":"H Loe","year":"2014","unstructured":"Loe H, Steinshamn S, Wisl\u00f8ff U. Cardio-respiratory reference data in 4631 healthy men and women 20\u201390 years: the HUNT 3 fitness study. PLoS ONE. 2014;9(11):e113884. https:\/\/doi.org\/10.1371\/journal.pone.0113884.","journal-title":"PLoS ONE"},{"issue":"41","key":"296_CR33","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"AR Lyon","year":"2022","unstructured":"Lyon AR, Lopez-Fernandez T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, et al. 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022;43(41):4229\u2013361. https:\/\/doi.org\/10.1093\/eurheartj\/ehac244.","journal-title":"Eur Heart J"},{"issue":"6","key":"296_CR34","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/j.1600-0838.2012.01445.x","volume":"23","author":"BM Nes","year":"2013","unstructured":"Nes BM, Janszky I, Wisl\u00f8ff U, St\u00f8ylen A, Karlsen T. Age-predicted maximal heart rate in healthy subjects: the HUNT fitness study. Scand J Med Sci Sports. 2013;23(6):697\u2013704. https:\/\/doi.org\/10.1111\/j.1600-0838.2012.01445.x.","journal-title":"Scand J Med Sci Sports"},{"issue":"9","key":"296_CR35","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1177\/2047487319877268","volume":"27","author":"K Hedman","year":"2020","unstructured":"Hedman K, Cauwenberghs N, Christle JW, Kuznetsova T, Haddad F, Myers J. Workload-indexed blood pressure response is superior to peak systolic blood pressure in predicting all-cause mortality. Eur J Prev Cardiol. 2020;27(9):978\u201387. https:\/\/doi.org\/10.1177\/2047487319877268.","journal-title":"Eur J Prev Cardiol"},{"key":"296_CR36","doi-asserted-by":"publisher","unstructured":"Berger A, Grossman E, Katz M, Kivity S, Klempfner R, Segev S, et al. Exercise blood pressure and the risk for future hypertension among normotensive middle-aged adults. J Am Heart Assoc. 2015;4(4). https:\/\/doi.org\/10.1161\/JAHA.114.001710.","DOI":"10.1161\/JAHA.114.001710"},{"issue":"3","key":"296_CR37","doi-asserted-by":"publisher","first-page":"203","DOI":"10.7326\/0003-4819-116-3-203","volume":"116","author":"MS Lauer","year":"1992","unstructured":"Lauer MS, Levy D, Anderson KM, Plehn JF. Is there a relationship between exercise systolic blood pressure response and left ventricular mass? The Framingham Heart Study. Ann Intern Med. 1992;116(3):203\u201310. https:\/\/doi.org\/10.7326\/0003-4819-116-3-203.","journal-title":"Ann Intern Med"},{"key":"296_CR38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40959-018-0035-0","volume":"4","author":"VW Li","year":"2018","unstructured":"Li VW, Liu AP, Ho KK, Yau JP, Cheuk DK, Cheung YF. Resting and exercise arterial dysfunction in anthracycline-treated adult survivors of childhood cancers. Cardiooncology. 2018;4:9. https:\/\/doi.org\/10.1186\/s40959-018-0035-0.","journal-title":"Cardiooncology"},{"issue":"5","key":"296_CR39","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.amjcard.2016.06.001","volume":"118","author":"P Vallerio","year":"2016","unstructured":"Vallerio P, Sarno L, Stucchi M, Musca F, Casadei F, Maloberti A, et al. Long-Term effects of Radiotherapy on arterial stiffness in breast Cancer Women. Am J Cardiol. 2016;118(5):771\u20136. https:\/\/doi.org\/10.1016\/j.amjcard.2016.06.001.","journal-title":"Am J Cardiol"},{"key":"296_CR40","doi-asserted-by":"publisher","first-page":"661464","DOI":"10.3389\/fphys.2021.661464","volume":"12","author":"G Novo","year":"2021","unstructured":"Novo G, Di Lisi D, Manganaro R, Manno G, Lazzara S, Immordino FA, et al. Arterial stiffness: effects of Anticancer drugs used for breast Cancer Women. Front Physiol. 2021;12:661464. https:\/\/doi.org\/10.3389\/fphys.2021.661464.","journal-title":"Front Physiol"},{"issue":"1","key":"296_CR41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40959-024-00222-4","volume":"10","author":"AW Bjerring","year":"2024","unstructured":"Bjerring AW, Smeland KH, Stokke T, Haugaa KH, Holte E, Rosner A, et al. Long-term cardiac effects of modern treatment for Hodgkin\u2019s lymphoma. Cardiooncology. 2024;10(1):19. https:\/\/doi.org\/10.1186\/s40959-024-00222-4.","journal-title":"Cardiooncology"},{"issue":"15","key":"296_CR42","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1200\/jco.21.01738","volume":"40","author":"ML Kwan","year":"2022","unstructured":"Kwan ML, Cheng RK, Iribarren C, Neugebauer R, Rana JS, Nguyen-Huynh M, et al. Risk of cardiometabolic risk factors in women with and without a history of breast Cancer: the pathways Heart Study. J Clin Oncol. 2022;40(15):1635\u201346. https:\/\/doi.org\/10.1200\/jco.21.01738.","journal-title":"J Clin Oncol"},{"issue":"7","key":"296_CR43","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.ejca.2008.10.037","volume":"45","author":"IK Larsen","year":"2009","unstructured":"Larsen IK, Sm\u00e5stuen M, Johannesen TB, Langmark F, Parkin DM, Bray F, et al. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer. 2009;45(7):1218\u201331. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.037.","journal-title":"Eur J Cancer"},{"issue":"1","key":"296_CR44","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.1093\/ije\/dyac095","volume":"52","author":"BO \u00c5svold","year":"2023","unstructured":"\u00c5svold BO, Langhammer A, Rehn TA, Kjelvik G, Gr\u00f8ntvedt TV, S\u00f8rgjerd EP, et al. Cohort Profile Update: the HUNT study, Norway. Int J Epidemiol. 2023;52(1):e80\u201391. https:\/\/doi.org\/10.1093\/ije\/dyac095.","journal-title":"Int J Epidemiol"},{"issue":"7","key":"296_CR45","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1177\/14034948221092294","volume":"50","author":"LA Hopstock","year":"2022","unstructured":"Hopstock LA, Grimsgaard S, Johansen H, Kanstad K, Wilsgaard T, Eggen AE. The seventh survey of the Tromso Study (Tromso7) 2015\u20132016: study design, data collection, attendance, and prevalence of risk factors and disease in a multipurpose population-based health survey. Scand J Public Health. 2022;50(7):919\u201329. https:\/\/doi.org\/10.1177\/14034948221092294.","journal-title":"Scand J Public Health"}],"container-title":["Cardio-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-024-00296-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40959-024-00296-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-024-00296-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T20:01:44Z","timestamp":1736020904000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiooncologyjournal.biomedcentral.com\/articles\/10.1186\/s40959-024-00296-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,4]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["296"],"URL":"https:\/\/doi.org\/10.1186\/s40959-024-00296-0","relation":{},"ISSN":["2057-3804"],"issn-type":[{"value":"2057-3804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,4]]},"assertion":[{"value":"1 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was given by all study participants. The study complies with the Declaration of Helsinki and was approved by the Regional Committees for Medical and Health Research Ethics (2019\/1318) and the Data Protection Services for Research (865175).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}